Press Release: ReachBio : ReachBio and abc biopply Partner to Intensify Support for De-Risking Pharma's Drug Development Process

Seattle-based primary cell biology CRO ReachBio and Swiss biotech abc biopply announced today a partnership to jointly co-market their preclinical test models. The two companies plan to support their clients with an even more predictive assay portfolio to further increase the efficiency of their drug discovery and development process.